Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ayobami Akenroye, M.B.,Ch.B.

Title
Institution
Department
Address
Phone
Profile Picture

Biography
Obafemi Awolowo University, Ile-Ife, NigeriaMBChB03/2008Medicine
Harvard T.H. Chan School of Public Health, Boston, MAMPH05/2011Public Health
Johns Hopkins Bloomberg School of Public Health, Baltimore, MDPhD08/2022Epidemiology

Overview

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. 4R00MD015767-03 (AKENROYE, AYOBAMI T) Jan 1, 2023 - Dec 31, 2025
    NIH/NIMHD
    Synthesizing Trial and Real-world Data on the Use of Biologics in Patients with Severe Asthma
    Role: Principal Investigator
  2. 1K99MD015767-01 (AKENROYE, AYOBAMI T) Dec 26, 2020 - Nov 30, 2022
    NIH
    Synthesizing Trial and Real-world Data on the Use of Biologics in Patients with Severe Asthma
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Nopsopon T, Lassiter G, Chen ML, Alexander GC, Keet C, Hong H, Akenroye A. Comparative efficacy of tezepelumab to mepolizumab, benralizumab, and dupilumab in eosinophilic asthma: A Bayesian network meta-analysis. J Allergy Clin Immunol. 2022 Dec 17. PMID: 36538979.
    Citations:    Fields:    
  2. Akenroye A, Ryan T, McGill A, Zhou G, Shier J, Segal J. Switch patterns in a cohort of individuals with asthma who received omalizumab or mepolizumab therapy. J Allergy Clin Immunol Pract. 2022 Nov 13. PMID: 36384205.
    Citations:    Fields:    
  3. Akenroye A, Zhou G, Jackson JW, Segal J, Alexander GC, Singh S. Incidence of adverse events prompting switching between biologics among adults with asthma: A retrospective cohort study. Allergy. 2022 Oct 26. PMID: 36286487.
    Citations:    Fields:    
  4. Akenroye A, Lassiter G, Jackson JW, Keet C, Segal J, Alexander GC, Hong H. Comparative efficacy of mepolizumab, benralizumab, and dupilumab in eosinophilic asthma: A Bayesian network meta-analysis. J Allergy Clin Immunol. 2022 Nov; 150(5):1097-1105.e12. PMID: 35772597; PMCID: PMC9643621.
    Citations:    Fields:    
  5. Tariq A, Akenroye A, Azar A, Seo P, Geetha D. Rituximab-associated hypogammaglobulinemia in ANCA-associated vasculitis: Incidence and time course. Eur J Rheumatol. 2022 Apr; 9(2):93-99. PMID: 35156624.
    Citations: 1     
  6. Hvisdas C, Louisias M, Laidlaw TM, Akenroye A. Addressing disparities in biologic drug development in the United States. J Allergy Clin Immunol. 2021 11; 148(5):1154-1156. PMID: 34530019.
    Citations:    Fields:    Translation:Humans
  7. Wu TD, Fawzy A, Akenroye A, Keet C, Hansel NN, McCormack MC. Metformin Use and Risk of Asthma Exacerbation Among Asthma Patients with Glycemic Dysfunction. J Allergy Clin Immunol Pract. 2021 11; 9(11):4014-4020.e4. PMID: 34293503; PMCID: PMC8675235.
    Citations: 2     Fields:    Translation:Humans
  8. Akenroye AT, Brunetti T, Romero K, Daya M, Kanchan K, Shankar G, Chavan S, Preethi Boorgula M, Ampleford EA, Fonseca HF, Hawkins GA, Pitangueira Teixeira HM, Campbell M, Rafaels N, Winters A, Bleecker ER, Cruz AA, Barreto ML, Meyers DA, Ortega VE, Figueiredo CA, Barnes KC, Checkley W, Hansel NN, Mathias RA. Genome-wide association study of asthma, total IgE, and lung function in a cohort of Peruvian children. J Allergy Clin Immunol. 2021 12; 148(6):1493-1504. PMID: 33713768; PMCID: PMC8429514.
    Citations: 5     Fields:    Translation:Humans
  9. Akenroye AT, Keet CA. Mentoring into productivity during fellowship: A working tripartite model. J Allergy Clin Immunol. 2021 05; 147(5):1627-1628. PMID: 33667478.
    Citations: 1     Fields:    Translation:Humans
  10. Akenroye AT, Heyward J, Keet C, Alexander GC. Lower Use of Biologics for the Treatment of Asthma in Publicly Insured Individuals. J Allergy Clin Immunol Pract. 2021 11; 9(11):3969-3976. PMID: 33556592; PMCID: PMC8549114.
    Citations: 2     Fields:    Translation:Humans
  11. Akenroye AT, Wood R, Keet C. Authors' response. Ann Allergy Asthma Immunol. 2020 09; 125(3):362. PMID: 32859352; PMCID: PMC7447208.
    Citations:    Fields:    Translation:HumansCellsPHPublic Health
  12. Akenroye AT, Wood R, Keet C. Asthma, biologics, corticosteroids, and coronavirus disease 2019. Ann Allergy Asthma Immunol. 2020 07; 125(1):12-13. PMID: 32387535.
    Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
  13. Akenroye A, McCormack M, Keet C. Severe asthma in the US population and eligibility for mAb therapy. J Allergy Clin Immunol. 2020 04; 145(4):1295-1297.e6. PMID: 31866437.
    Citations: 4     Fields:    Translation:HumansCells
  14. Akenroye A, Keet C. Underrepresentation of blacks, smokers, and obese patients in studies of monoclonal antibodies for asthma. J Allergy Clin Immunol Pract. 2020 02; 8(2):739-741.e6. PMID: 31472296.
    Citations: 4     Fields:    Translation:Humans
  15. Akenroye AT, Ajala A, Azimi-Nekoo E, de Vos GS. Prevalence of anaphylaxis among adults admitted to critical care for severe asthma exacerbation. Emerg Med J. 2018 Oct; 35(10):623-625. PMID: 30093380.
    Citations:    Fields:    Translation:Humans
  16. Akenroye AT, McEwan C, Saini SS. Montelukast reduces symptom severity and frequency in patients with angioedema-predominant chronic spontaneous urticaria. J Allergy Clin Immunol Pract. 2018 Jul - Aug; 6(4):1403-1405. PMID: 29733981.
    Citations: 4     Fields:    Translation:Humans
  17. Akenroye AT, Kumthekar AA, Alevizos MK, Mowrey WB, Broder A. Implementing an Electronic Medical Record-Based Reminder for Cardiovascular Risk Screening in Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2017 05; 69(5):625-632. PMID: 27390217.
    Citations: 9     Fields:    Translation:HumansPHPublic Health
  18. Iammatteo M, Akenroye A, Jariwala S, Lee B, Schairer D, Rosenstreich D. Severe contact dermatitis due to ethylenediamine dihydrochloride in nystatin cream. J Allergy Clin Immunol Pract. 2017 Sep - Oct; 5(5):1448-1450. PMID: 28396110.
    Citations:    Fields:    Translation:Humans
  19. Akenroye AT, Iammatteo M, de Vos GS. Hyper-immunoglobulin E-like syndrome in a patient with multiple genetic mutations. Ann Allergy Asthma Immunol. 2017 May; 118(5):643-644. PMID: 28366583.
    Citations: 1     Fields:    Translation:Humans
  20. Akenroye AT, Madan N, Mohammadi F, Leider J. Hemophagocytic Lymphohistiocytosis mimics many common conditions: case series and review of literature. Eur Ann Allergy Clin Immunol. 2017 Jan; 49(1):31-41. PMID: 28120605.
    Citations: 17     Fields:    Translation:Humans
  21. Iammatteo M, Ferastraoaru D, Koransky R, Alvarez-Arango S, Thota N, Akenroye A, Jerschow E. Identifying Allergic Drug Reactions Through Placebo-Controlled Graded Challenges. J Allergy Clin Immunol Pract. 2017 May - Jun; 5(3):711-717.e2. PMID: 27888028.
    Citations: 7     Fields:    Translation:HumansPHPublic Health
  22. Akenroye AT, Stack AM. The development and evaluation of an evidence-based guideline programme to improve care in a paediatric emergency department. Emerg Med J. 2016 Feb; 33(2):109-17. PMID: 26150121.
    Citations: 7     Fields:    Translation:Humans
  23. Akenroye AT, Thurm CW, Neuman MI, Alpern ER, Srivastava G, Spencer SP, Simon HK, Tejedor-Sojo J, Gosdin CH, Brennan E, Gottlieb LM, Gay JC, McClead RE, Shah SS, Stack AM. Prevalence and predictors of return visits to pediatric emergency departments. J Hosp Med. 2014 Dec; 9(12):779-87. PMID: 25338705.
    Citations: 20     Fields:    Translation:Humans
  24. Akenroye AT, Baskin MN, Samnaliev M, Stack AM. Impact of a bronchiolitis guideline on ED resource use and cost: a segmented time-series analysis. Pediatrics. 2014 Jan; 133(1):e227-34. PMID: 24324000.
    Citations: 27     Fields:    Translation:Humans
  25. Akenroye OO, Adebona OT, Akenroye AT. Surgical Care in the Developing World-Strategies and Framework for Improvement. J Public Health Afr. 2013 Dec 03; 4(2):e20. PMID: 28299109.
    Citations: 8     
  26. Volpe D, Harrison S, Damian F, Rachh P, Kahlon PS, Morrissey L, Mack J, Akenroye A, Stack AM. Improving timeliness of antibiotic delivery for patients with fever and suspected neutropenia in a pediatric emergency department. Pediatrics. 2012 Jul; 130(1):e201-10. PMID: 22711718.
    Citations: 15     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Akenroye's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (137)
Explore
_
Co-Authors (8)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.